Clinical studies recruiting near Canberra

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease
NA · Canberra Hospital · Efemoral Medical, Inc. · NCT04584632 Observational Study Protocol: LIVER-R
Phase N/A · AstraZeneca · NCT06252753 Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
NA · Saluda Medical Pty Ltd · NCT04662905 CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
Phase N/A · Canberra Health Services · Clinical Hub for Interventional Research (CHOIR) · NCT07313059 Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · TRex Bio, Inc. · NCT06934252 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · Monash University · NCT05678621 Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera · NCT07284979 ROADMAP Clinical Trial
Phase 4 · University of Newcastle, Australia · NCT06771050 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Takeda · NCT06499285 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site AU002 · Incyte Corporation · NCT07522073 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Canberra Hospital · Eli Lilly and Company · NCT07223593 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · Canadian Cancer Trials Group · NCT05640999 A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase N/A · Swedish Orphan Biovitrum · NCT05776472 The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Phase 3 · The George Institute · NCT06058585 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherap
Phase 2/Phase 3 · AbbVie · NCT07155187 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Nordic Lymphoma Group · NCT04332822 Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder
Phase 2 · HB BioTech, LLC · NCT07499440 The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · University of Leicester · NCT04204915 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · Bayer · NCT06452277 A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 i
Phase 3 · The Canberra Hospital · Incyte Corporation · NCT07284849 Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years
Phase 1/Phase 2 · Sanofi · NCT06891417 MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · Intellia Therapeutics · NCT06128629 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Mirati Therapeutics Inc. · NCT04613596 The EXCEL Registry of Patients Requiring ECMO
Phase N/A · Canberra Hospital · Australian and New Zealand Intensive Care Research Centre · NCT03793257 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Amgen · NCT07136012 ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NA · Canberra Alliance for Harm Minimisation & Advocacy (CAHMA) · Kirby Institute · NCT03685045 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652 The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Phase 3 · Boehringer Ingelheim · NCT06872892 Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Phase 4 · The Canberra Hospital · University of Sydney · NCT02823821 A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multipl
Phase 3 · Canberra Hospital · European Myeloma Network B.V. · NCT06932562

Look up another city

Look up another condition